Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years

The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthFood and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years

The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.

View Premium plansBrowse free archive reports